| IEM | Inborn Errors of Metabolism |
| MetS | Metabolic Syndrome |
| BMI | Body Mass Index |
| GH | Growth Hormone |
| IGF1 | Insulin-like growth factor 1 |
| FSH | Follicle Stimulating Hormone |
| LH | Luteinizing Hormone |
| ACTH | Adrenocorticotropic Hormone |
| T2DM | Type 2 Diabetes Mellitus |
| PKU | Phenylketonuria |
| MSUD | Maple Syrup Urine Disease |
| PA | Propionic Acidemia |
| MMA | Methylmalonic Acidemia |
| BCKD | Branched-Chain Ketoacid Dehydrogenase |
| BCAA | Branched-chain amino acids |
| TCA-cycle | Tricarboxylic Acid Cycle |
| MCAD | Medium-Chain Acyl-CoA Dehydrogenase deficiency |
| VLCAD | Very Long-ChainAcyl-CoA Dehydrogenase deficiency |
| LCHAD | Long-Chain 3-hydroxyacyl-CoA Dehydrogenase deficiency |
| CPT1 | Carnitine Palmityoltransferase 1 |
| CPT2 | Carnitine Palmityoltransferase 2 |
| CACT | Carnitine-Acylcarnitine Translocase |
| GSD | Glycogen Storage Diseases |
| CDG | Congenital Disorders of Glycosylation |
| NEFA | Non-Esterified Fatty Acids |
| POI | Premature Ovarian Insufficiency |
| HRT | Hormone Replacement Therapy |
| ARS2 | Aminoacyl-tRNA syntethase 2 deficiency |
| LSD | Lysosomal Storage Disease |
| PP | Precocious Puberty |
| ROS | Reactive Oxygen Species |
| IRS | Insulin Receptor Substrates |
| mTORC1 | MechanisticTarget of Rapamycin complex 1 |
| JNK | c-Jun N-Terminal Kinase |
| MAPK | p38 Mitogen-Activated Protein Kinase |